Mechanically speaking, Ang II treatment significantly increased the level of miR-199a-5p, thereby promoting VSMCs senescence to participate in the formation of AAA by inhibiting the expression of SIRT1 (117). The gene discussed is AGT; the disease is triple-A syndrome.